October 31, 2024 | Volume XV | Issue 44

Medicare delivers positive report on value-based programs

Healthcare Dive reports:


Medicare’s largest value-based care program saved the government more than $2.1 billion last year — an all-time record, according to the CMS.


Accountable care organizations, groups of providers that join together to manage the care of a patient population, also benefited, receiving performance payments of $3.1 billion in 2023. That’s also a historic high since the Medicare Shared Savings Program was formed more than one decade ago.


The quality of ACOs is also rising, the CMS said. Regulators specifically called out improvement in measures related to diabetes and blood pressure control, statin therapy for cardiovascular diseases and screening for depression, fall risk and breast and colorectal cancers.

Read More

When ribosomes go rogue

Tim Vernimmen | Knowable Magazine


In the 1940s, scientists at the recently established National Cancer Institute were trying to breed mice that could inform our understanding of cancer, either because they predictably developed certain cancers or were surprisingly resistant.


The team spotted a peculiar litter in which some baby mice had short, kinked tails and misplaced ribs growing out of their neck bones. The strain of mice, nicknamed “tail short,” has been faithfully bred ever since, in the hope that one day, research might reveal what was the matter with them.


After more than 60 years, researchers finally got their answer, when Maria Barna, a developmental biologist then at the University of California San Francisco, found that the mice had a genetic mutation that caused a protein to disappear from their ribosomes — the places in cells where proteins are made.


This came as a complete surprise, says Barna. Everyone had expected the cause to be a mutation in a gene that orchestrated development, not one involved in ribosome structure. Ribosomes, which under the microscope look like millions of specks scattered across the cell, or — closer up — like a bread roll torn into...

Read More

Will the anti-obesity wonder drugs work wonders for the US economy?

James Pethokoukis writes for Faster, Please!:


It could be argued — quite fairly! — that this newsletter spends slightly too much time discussing and analyzing recent developments in artificial intelligence and their potential impact on the American economy. That, at least, versus what's been happening with GLP-1 receptor agonists: weight-loss drugs such as Ozempic and Wegovy. The GLP-1 agonists, according to a new big piece in The Economist...

Read More

Tuberculosis infected 8 million people last year, the most WHO has ever tracked

WXYZ-TV Detroit | Channel 7


In today’s Health Alert, Tuberculosis cases have hit record highs, with over 8 million people infected worldwide last year. The WHO says this is the highest number they've tracked.

Watch the video HERE.

Inside

FloridaHealthIndustry.com

Focus

Compliance Update

Best Practices

Healthcare Headlines

Game Changers

Last Word

Publisher of Week in Review, Specialty Focus, FHIweekly & Game Changers